BUY Indus Towers — Nooresh Merani
byNooresh MeraniHorizon: NA (inferred Swing (≤2wk))12 May 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·11 May · yesterday
Indus Towers Limited announced its audited consolidated financial results for the fourth quarter and full year ended March 31, 2026. The company reported consolidated revenues of Rs. 32,493 Crores for
BSE · Company Update·30 Apr · 2w ago
Indus Towers Limited has incorporated a Wholly Owned Subsidiary (WOS) in the International Financial Services Centre (IFSC), GIFT City.
NSE · Acquisition·29 Apr · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Indus Towers
- BUY — Ansh Jogendra Bhilwar9 Oct 2026 · ~2 weeks · target ₹385 · Target hit
- BUY — Ansh Jogendra Bhilwar7 Oct 2026 · Same day · target ₹410 · Expired
- BUY — Osho Krishan, Angel One6 Oct 2026 · ~3 months · target ₹400 · Active
- BUY — Rakesh Bansal6 Oct 2026 · ~2 weeks · target ₹400 · SL hit
- BUY — Elara Capital6 Oct 2026 · ~1 year · target ₹495 · Active
More from Nooresh Merani
- BUY Northern Arc Capital22 Sept 2026 · ~2 weeks · target ₹360 · SL hit
- BUY City Union Bank22 Sept 2026 · ~2 weeks · target ₹260 · SL hit
- BUY Aurobindo Pharma12 Aug 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY Shriram Finance12 Aug 2026 · ~2 weeks · target ₹1,220 · SL hit
- BUY Metropolis Healthcare28 Jul 2026 · ~2 weeks · target ₹650 · SL hit

